Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research

Showing results (651-660 of 49,958) with videos related to

Pageof 4,996
Sort By:
Cancer Research|May 17, 2003
BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- miceAnneke C Blackburn, Jennifer S Brown, Stephen P Naber, et al.
Cancer Research|May 17, 2003
Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesisKazuhiro Chida, Takeshi Hara, Takaaki Hirai, et al.
Cancer Research|May 17, 2003
Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibilityYi-Ping Fu, Jyh-Cherng Yu, Ting-Chih Cheng, et al.
Cancer Research|May 17, 2003
Therapeutic targeting of the endothelin a receptor in human ovarian carcinomaLaura RosanĂ², Francesca Spinella, Debora Salani, et al.
Cancer Research|May 17, 2003
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiformeLoi K Phuong, Cory Allen, Kah-Whye Peng, et al.
Cancer Research|May 17, 2003
High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse modelMing Wu, Richard Mazurchuk, Neeta D Chaudhary, et al.
Cancer Research|May 17, 2003
Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challengeLakshmi Krishnan, Subash Sad, Girishchandra B Patel, et al.
Cancer Research|May 17, 2003
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanomaRoberta Mortarini, Adriano Piris, Andrea Maurichi, et al.
Cancer Research|May 17, 2003
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cellsShujie Zhao, Kolaparthi Venkatasubbarao, Senlin Li, et al.
Cancer Research|May 17, 2003
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cellsGeorge L Barnes, Amjad Javed, Sylvan M Waller, et al.
Pageof 4,996

Showing results (651-660 of 49,958) with videos related to

Sort By:
Pageof 4,996
Cancer Research|May 17, 2003
BALB/c alleles for Prkdc and Cdkn2a interact to modify tumor susceptibility in Trp53+/- miceAnneke C Blackburn, Jennifer S Brown, Stephen P Naber, et al.
Cancer Research|May 17, 2003
Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesisKazuhiro Chida, Takeshi Hara, Takaaki Hirai, et al.
Cancer Research|May 17, 2003
Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibilityYi-Ping Fu, Jyh-Cherng Yu, Ting-Chih Cheng, et al.
Cancer Research|May 17, 2003
Therapeutic targeting of the endothelin a receptor in human ovarian carcinomaLaura RosanĂ², Francesca Spinella, Debora Salani, et al.
Cancer Research|May 17, 2003
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiformeLoi K Phuong, Cory Allen, Kah-Whye Peng, et al.
Cancer Research|May 17, 2003
High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse modelMing Wu, Richard Mazurchuk, Neeta D Chaudhary, et al.
Cancer Research|May 17, 2003
Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challengeLakshmi Krishnan, Subash Sad, Girishchandra B Patel, et al.
Cancer Research|May 17, 2003
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanomaRoberta Mortarini, Adriano Piris, Andrea Maurichi, et al.
Cancer Research|May 17, 2003
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cellsShujie Zhao, Kolaparthi Venkatasubbarao, Senlin Li, et al.
Cancer Research|May 17, 2003
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cellsGeorge L Barnes, Amjad Javed, Sylvan M Waller, et al.
Pageof 4,996